Curettage vs Electrodessication for Paediatric Molluscum Contagiosum: Efficacy and Safety Follow-Up Study

Authors

  • Daniel Hilewitz Pediatric Dermatology Unit, The Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel; Grey Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel
  • Efrat Bar-Ilan Pediatric Dermatology Unit, The Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel; Grey Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel
  • Noa Hadayer Pediatric Dermatology Unit, The Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel
  • Ayelet Ollech Grey Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel; Current affiliation: Pediatric Dermatology Service, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
  • Tal Kind Pediatric Dermatology Unit, The Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel
  • Shoshana Greenberger Pediatric Dermatology Unit, The Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel; Grey Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel

DOI:

https://doi.org/10.2340/actadv.v105.44300

Keywords:

Molluscum Contagiosum, recurrence, curettage, aesthetics, scar

Abstract

Molluscum contagiosum (MC) is a common paediatric cutaneous infection caused by a DNA poxvirus, resulting in lesions that often impair patients’ quality of life. Although MC typically resolves spontaneously, parents frequently seek treatment due to cosmetic concerns, pruritus, or fear of lesion spread. Currently, there is no gold standard treatment, and various therapeutic modalities – including curettage and electrodessication (ED) – are utilized in clinical practice. This prospective comparative study aimed to compare efficacy, cosmetic outcome, and patient satisfaction with curettage vs ED as treatment methods in the treatment of MC. The study included 103 paediatric patients presenting with confirmed MC and ≥ 10 lesions (or 5 on face), treated at Sheba Medical Center. Treatment allocation to either curettage or ED was based on guardian preference. Data collected included demographic and clinical characteristics, procedural outcomes, pain levels, and satisfaction ratings. Structured questionnaires were administered 6 weeks post-procedure to evaluate outcomes, including lesion recurrence, infection, remnants, healing duration, and patient/parent satisfaction. Statistical analyses were conducted, with statistical significance defined as p ≤ 0.05. Among the cohort (mean age, 4.37 years; 60% female), 67 (61.7%) patients were treated with curettage and 42 (38.3%) with ED. Most presented with facial lesions (67.96%) and multiple lesion sites (50.5%). Patients treated with curettage reported fewer remnants (42.9% vs 70%, p = 0.007), greater aesthetic satisfaction (p = 0.039), and faster recovery (p = 0.050). Pain levels were comparable between groups, but higher 1-week post-procedure in ED (p = 0.014). Recurrence rates were similar for both methods (49.2% curettage, 35% ED). Curettage offers clear advantages over ED for the treatment of MC, resulting in superior aesthetic outcomes, faster recovery, and lower post-procedural pain. Therefore, curettage should generally be preferred, while ED may be considered for precise interventions in sensitive anatomical areas.

Downloads

Download data is not yet available.

References

Braue A, Ross G, Varigos G, Kelly H. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol 2005; 22: 287–294. DOI: https://doi.org/10.1111/j.1525-1470.2005.22401.x

Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134: 1527–1534. DOI: https://doi.org/10.1038/jid.2013.446

Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol. 1994; 33: 453–461. DOI: https://doi.org/10.1111/j.1365-4362.1994.tb02853.x

Basdag H, Rainer BM, Cohen BA. Molluscum contagiosum: to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States. Pediatr Dermatol 2015; 32: 353-357. DOI: https://doi.org/10.1111/pde.12504

Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract 2014; 31: 130–136. DOI: https://doi.org/10.1093/fampra/cmt075

Koning S, Bruijnzeels MA, van Suijlekom-Smit LW, van der Wouden JC. Molluscum contagiosum in Dutch general practice. Br J Gen Pract J R Coll Gen Pract 1994; 44: 417–419.

Villa L, Varela JA, Otero L, Sánchez C, Junquera ML, Río JS del, et al. Molluscum contagiosum: a 20-year study in a sexually transmitted infections unit. Sex Transm Dis 2010; 37: 423–424. DOI: https://doi.org/10.1097/OLQ.0b013e3181cfca1c

McCollum AM, Holman RC, Hughes CM, Mehal JM, Folkema AM, Redd JT, et al. Molluscum contagiosum in a pediatric American Indian population: incidence and risk factors. PloS One 2014; 9: e103419. DOI: https://doi.org/10.1371/journal.pone.0103419

Dohil MA, Lin P, Lee J, Lucky AW, Paller AS, Eichenfield LF. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol 2006; 54: 47–54. DOI: https://doi.org/10.1016/j.jaad.2005.08.035

Silverberg NB. Pediatric molluscum: an update. Cutis 2019; 104: 301–305; E1; E2.

Wollenberg A, Wetzel S, Burgdorf WHC, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003; 112: 667–674. DOI: https://doi.org/10.1016/j.jaci.2003.07.001

Andre N, Jurban E, Alyagon A, Moskovich C, Kaplan O, Test G, et al. Facial vs non-facial molluscum contagiosum infection in children: a cross-sectional study. Acta Derm Venereol 2024; 104: adv40091. DOI: https://doi.org/10.2340/actadv.v104.40091

Andre N, Alyagon A, Jurban E, Moscovici K, Horev A. Does molluscum contagiosum need to be managed differently in atopic children? Acta Derm Venereol 2024; 104: adv39983. DOI: https://doi.org/10.2340/actadv.v104.39983

Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infect Dis 2015; 15: 190–195. DOI: https://doi.org/10.1016/S1473-3099(14)71053-9

van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev 2017; 2017: CD004767. DOI: https://doi.org/10.1002/14651858.CD004767.pub4

Forbat E, Al-Niaimi F, Ali FR. Molluscum contagiosum: review and update on management. Pediatr Dermatol 2017; 34: 504–515. DOI: https://doi.org/10.1111/pde.13228

Nguyen HP, Franz E, Stiegel KR, Hsu S, Tyring SK. Treatment of molluscum contagiosum in adult, pediatric, and immunodeficient populations. J Cutan Med Surg 2014; 18: 299–306. DOI: https://doi.org/10.2310/7750.2013.13133

Molluscum Contagiosum Treatment & Management: Approach Considerations, Pharmacologic Therapy, Benign Neglect 2024 Jan 9 [cited 2025 Mar 24]. Available from: https://emedicine.medscape.com/article/910570-treatment#d12?form=fpf

Butala N, Siegfried E, Weissler A. Molluscum BOTE sign: a predictor of imminent resolution. Pediatrics 2013; 131: e1650–1653. DOI: https://doi.org/10.1542/peds.2012-2933

Sil A, Bhanja DB, Chandra A, Biswas SK. BOTE sign in molluscum contagiosum. BMJ Case Rep CP 2020; 13: e239142. DOI: https://doi.org/10.1136/bcr-2020-239142

Simonart T, De Maertelaer V. Curettage treatment for molluscum contagiosum: a follow-up survey study. Br J Dermatol 2008; 159: 1144–1147. DOI: https://doi.org/10.1111/j.1365-2133.2008.08833.x

Harel A, Kutz AM, Hadj-Rabia S, Mashiah J. To treat molluscum contagiosum or not – curettage: an effective, well-accepted treatment modality. Pediatr Dermatol 2016; 33: 640–645. DOI: https://doi.org/10.1111/pde.12968

Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol 2006; 23: 574–579. DOI: https://doi.org/10.1111/j.1525-1470.2006.00313.x

Published

2025-10-08

How to Cite

Hilewitz, D., Bar-Ilan, E., Hadayer, N., Ollech, A., Kind, T., & Greenberger, S. (2025). Curettage vs Electrodessication for Paediatric Molluscum Contagiosum: Efficacy and Safety Follow-Up Study. Acta Dermato-Venereologica, 105, adv44300. https://doi.org/10.2340/actadv.v105.44300

Issue

Section

Articles